Inside the Laboratory: Grinias Research Lab at Rowan University, Part II – Graduate Student Interviews
In this continuing series from LCGC, we go on location to the Grinias Research Lab at Rowan University and speak to graduate students about their backgrounds, research interests, and future plans.
Welcome to this installment of "Inside the Laboratory" in which the LCGC editorial team leaves their New Jersey office and ventures out in the field, with the goal of giving our audience a window into the next generation of analytical chemists.
Rowan University in Glassboro, New Jersey, is home to the Grinias Research Lab headed by James Grinias, a professor in the department of Chemistry & Biochemistry. Jim’s introductory interview for this part of the series was shared on the LCGC website in March.
LCGC will be releasing further video interviews with Grinias’ students as well as footage from inside the lab, and even instrumentation demonstrations, in the coming weeks.
Check back soon for more from Rowan University!
SPE-Based Method for Detecting Harmful Textile Residues
January 14th 2025University of Valencia scientists recently developed a method using solid-phase extraction (SPE) followed by high-performance liquid chromatography coupled to high-resolution mass spectrometry (HPLC–HRMS/MS) for detecting microplastics and other harmful substances in textiles.
PFAS Analysis in Practice: A RAFA 2024 Interview with Stefan van Leuwen
January 10th 2025At the Recent Advances in Food Analysis (RAFA) conference in 2024, LCGC International sat down with Stefan van Leuwen of Wageningen Food Safety Research to discuss his research, which addresses emerging challenges in circular food production, focusing on the risks posed by pollutants when waste and by-products are repurposed in food systems.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
